Literature DB >> 21196730

Acute kidney infarction secondary to intracardiac thrombus embolization in a patient with ischemic dilated cardiomyopathy.

Mehmet Mustafa Can1, Ibrahim Halil Tanboğa, Hacer Ceren Demircan, Alper Ozkan, Fatih Koca, Nurşen Keleş, Kenan Sönmez, Cihangir Kaymaz, Victor Serebruany.   

Abstract

Acute renal infarction due to emboli represents a very rare but significant threat for kidney loss, and the clinical presentation is challenging. The differential diagnosis of massive renal thrombi includes all other causes of abdominal pain, and they can be easily misdiagnosed as renal colic due to nephrolithiasis. Although there are a few case reports regarding the possibility that cardiac emboli may cause acute kidney infarction, intracardiac thrombi within the ventricular cavity diagnosed by echocardiography as a cause of such renal artery occlusion have never been reported in patients with cardiomyopathy. Herein, we describe a 39-year-old male with a history of ischemic dilated cardiomyopathy. He was admitted to our hospital with left upper abdominal pain and vomiting. After serial examinations and tests, the diagnosis of acute renal infarction due to intracardiac thrombus embolization as a result of severely reduced cardiac function was made.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 21196730     DOI: 10.1159/000322510

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  2 in total

1.  An uncommon cause of acute flank pain: renal infarction.

Authors:  Giuseppe De Matteis; Federica Cutillo; Andrea Contegiacomo; Angelo Santoliquido; Giovanni Gambassi
Journal:  Intern Emerg Med       Date:  2018-12-06       Impact factor: 3.397

2.  Reccurent thrombus in the gigantic left atrium during effective anticoagulant therapy: case report.

Authors:  Lucia Masarova; Jan Novak; Martin Pesl; Jiri Ondrasek; Jiri Semenka; Eva Simarova; Roman Panovsky
Journal:  BMC Cardiovasc Disord       Date:  2020-02-21       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.